October 2024 - Page 3 of 15

MondayOct 28, 2024 9:00 am

Join Daymond John at NobleCon20 to Hear from World-Class Headliners

Daymond John, one of the most recognized investors from ABC's Shark Tank, is gearing up for the 20th Emerging Growth Equity Conference hosted by Noble Capital Markets on December 3rd and 4th in Boca Raton, Florida. He’ll be alongside fellow investors Robert Herjavec and Kevin O'Leary, promising an engaging and insightful experience for all attendees. This conference will showcase innovative companies and provide a unique platform for entrepreneurs to present their ideas. Don’t miss this exciting opportunity to learn, network and potentially discover the next big investment! To learn more about the event and what to expect, get Daymond John’s…

FridayOct 25, 2024 3:01 pm

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Eyes Prospective Horizon at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) recently released an update regarding its Storm Copper Project’s 2024 drilling exploration program. The program focused on expansion at the Cyclone and Chinook Prospects and delineation drilling at the Lightning Ridge discovery and Thunder Prospect. “The first deep drill hole of the year adds another success to the 2024 exploration program at Storm,” said Aston Bay CEO Thomas Ullrich. “The style of copper mineralization intercepted and its stratigraphic location is similar to Cyclone — this may be the fault-offset southern portion of the deposit and could add to a potential future resource. “In addition…

FridayOct 25, 2024 1:48 pm

QualityStocksNewsBreaks – GolfLync’s Traction, Market Fit and Experienced Executive Team Underscore Its Investment Opportunity

GolfLync, the company behind the GolfLync app – a social network for matching golf games and players, is currently in a stage reminiscent of Flip: a promising startup with a unique value proposition. A recent article reads, “Originally launched with the goal of creating a community-driven platform for golfers, GolfLync combines social networking with features tailored to the sport, such as event coordination, performance tracking and golf-related content sharing… The app’s market fit, proven user acquisition, traction and experienced executive team make it an investment worth looking at closely. In addition, GolfLync is now building on its initial success and…

FridayOct 25, 2024 11:15 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX): Tapping into Argentina’s Growing Copper Potential

Argentina is rapidly emerging as a key player in the global mining industry, positioning itself to become a significant producer of copper and other minerals critical to the world’s clean energy transition. The country’s ambition to rank among the top ten copper producers by 2030 reflects its immense potential, driven by vast untapped mineral reserves, recent policy reforms, and a growing pipeline of mining projects. Currently, Argentina holds an estimated 75.5 million metric tons of copper reserves, representing about 3% of the global total (https://ibn.fm/XkBiO). Although this is modest compared to copper giants like Chile and Peru, Argentina’s improving investment…

FridayOct 25, 2024 10:40 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program

Calidi Biotherapeutics (NYSE American: CLDI), a leader in oncolytic virotherapy (OV) for cancer, will feature in a RedChip Small Stocks, Big Money™ interview on Bloomberg TV on Oct. 26 at 7 p.m. ET. During the interview, Calidi’s Chief Business Officer, Stephen Thesing, provides an update on Calidi’s innovative approach, which uses engineered viruses to target and eliminate cancer cells. Calidi’s proprietary cell-based technology enhances the potency and longevity of these viruses by protecting them from immune response, boosting treatment efficacy. With IV-based and direct tumor administration methods, Calidi is advancing a new frontier in cancer treatment within the multi-billion-dollar oncology…

FridayOct 25, 2024 10:30 am

Report: Robots Are Revolutionizing Hospitality; Nightfood Holdings Inc.’s (NGTF) Game-Changing Automation Gameplan Revealed

The International Federation of Robotics released its latest report on the state of the robotics industry, showing a 30% surge in sales in 2023 to over 205,000 units The surge aligns perfectly with Nightfood Holdings recent acquisitions focused on the booming robotics revolution in hospitality Nightfood acquired Future Hospitality Ventures earlier this year and is acquiring the world-renowned Los Angeles Cooking School, training chefs and foodservice operators in the implementation of robotics, supplied through an innovative “Robotics-as-a-Service” business model As hospitality businesses grapple with labor shortages and rising operational costs, a single stark reality has set in: automate or die.…

FridayOct 25, 2024 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Gets FDA Clearance for Buntanetap Pivotal Phase 3 Trials, Market Enthusiasm Highlighted in GuruFocus Article

Financial research platform GuruFocus underlines Annovis’ unique approach to tackling neurodegenerative conditions such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”). The FDA's decision to allow the company to go to Phase 3, points to the fact that lead drug candidate buntanetap may be an effective treatment for AD, one of the most critical diseases in an aging society. Buntanetap has been shown to significantly improve cognition in early AD patients, both by itself or on top of existing therapies. The Phase 3 program will consist of two trials: a 6-month study aimed at confirming buntanetap’s symptomatic benefits and an…

FridayOct 25, 2024 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Discusses Quantum Optimization, Presents Customer Success Stories at 2024 INFORMS Annual Meeting

D-Wave’s Vice President of Quantum Technology Evangelism, Murray Thom, was a featured speaker at the event’s Technology Showcase, detailing how D-Wave quantum technologies can tackle complex optimization problems. D-Wave’s Staff Technical Advisor Catherine Potts led an exhibitor workshop covering the fundamentals of quantum computing and demonstrated real-world cases. Participants were given the opportunity to explore D-Wave’s Leap(TM) real-time quantum cloud service, which features a portfolio of hybrid solvers able to deal with problems involving millions of variables and constraints. The 2024 INFORMS Annual Meeting was expected to attract 6,000 attendees, including members, students, prospective employers and employees, as well as…

ThursdayOct 24, 2024 3:53 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Is at the Forefront of the EM Sector with Cutting-Edge Technology

SuperCom (NASDAQ: SPCB) is leveraging its electronic monitoring (“EM”) platform as a cutting-edge solution that is ahead of the curve in what is still a niche market. Its client list in Europe and the United States is continuing to grow. EM technology is becoming increasingly popular among European governments to advance the social inclusion of criminal offenders through probationary services, reducing recidivism. The company recently announced $2.6 million in new orders from European governments. “We are delighted to continue strengthening our collaboration with European governments,” said SuperCom President and CEO Ordan Trabelsi. “It highlights our leadership in the electronic monitoring…

ThursdayOct 24, 2024 1:05 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced an upcoming meeting with U.S. Food and Drug Administration (“FDA”) leadership. The focus is to discuss Clene’s CNM-Au8® biomarker and related clinical and survival data for ALS. “FDA’s Director of the Office on New Drugs, the Director of the Office of Neuroscience, and the Division of Neurology 1 (‘DN1’) review team, as well as recognized key opinion leaders in ALS,…

Site Search

Company Search

Month: October 2024